共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R019225-10mg | 10mg | 5~7个工作日 |
N-(4-(N-(3-((3,5-二甲氧基苯基)氨基)喹... N-[4-[[[3-[(3,5-dimetho... |
98% |
|
|
罗恩 | R019225-5mg | 5mg | 5~7个工作日 |
N-(4-(N-(3-((3,5-二甲氧基苯基)氨基)喹... N-[4-[[[3-[(3,5-dimetho... |
98% |
|
|
阿拉丁 | S129513-5mg | 5mg | 现货 |
SAR245409 (XL765) SAR245409 (XL765) |
≥98% |
|
|
阿拉丁 | S129513-10mg | 10mg | 现货 |
SAR245409 (XL765) SAR245409 (XL765) |
≥98% |
|
|
阿拉丁 | S129513-50mg | 50mg | 现货 |
SAR245409 (XL765) SAR245409 (XL765) |
≥98% |
|
|
阿拉丁 | V408014-1ml | 1ml | 现货 |
Voxtalisib (XL765) Analogue Voxtalisib (XL765) Analogue |
10mM in DMSO |
|
|
凯为 | JZ009DEF-50mg | 50mg | 现货 |
N-(4-(N-(3-((3,5-二甲氧基苯基)氨基)喹... XL765 |
98+% |
|
|
凯为 | JZ009DEF-100mg | 100mg | 现货 |
N-(4-(N-(3-((3,5-二甲氧基苯基)氨基)喹... XL765 |
98+% |
|
|
凯为 | JZ009DEF-5mg | 5mg | 现货 |
N-(4-(N-(3-((3,5-二甲氧基苯基)氨基)喹... XL765 |
98+% |
|
|
凯为 | JZ009DEF-10mg | 10mg | 现货 |
N-(4-(N-(3-((3,5-二甲氧基苯基)氨基)喹... XL765 |
98+% |
|
|
毕得 | BD305560-10mg | 10mg | 现货 |
N-(4-(N-(3-((3,5-二甲氧基苯基)氨基)喹... N-(4-(N-(3-((3,5-Dimethoxyph... |
98+% |
|
|
毕得 | BD305560-50mg | 50mg | 现货 |
N-(4-(N-(3-((3,5-二甲氧基苯基)氨基)喹... N-(4-(N-(3-((3,5-Dimethoxyph... |
98+% |
|
|
毕得 | BD305560-5mg | 5mg | 现货 |
N-(4-(N-(3-((3,5-二甲氧基苯基)氨基)喹... N-(4-(N-(3-((3,5-Dimethoxyph... |
98+% |
|
|
百灵威 | JK1835029-10MG | 10MG | 35天 |
Voxtalisib 类似物 Voxtalisib analogue, 98%, a ... |
98% |
|
|
源叶 | S42210-5mg | 5mg | 现货 |
SAR245409 (XL765) SAR245409 (XL765) |
≥98% |
|
|
源叶 | S42210-10mg | 10mg | 现货 |
SAR245409 (XL765) SAR245409 (XL765) |
≥98% |
|
|
源叶 | S42210-50mg | 50mg | 现货 |
SAR245409 (XL765) SAR245409 (XL765) |
≥98% |
|
|
源叶 | T93281-1ml | 1ml | 期货,请咨询 |
Voxtalisib (XL765) Analogue Voxtalisib (XL765) Analogue |
10mM in DMSO |
|
|
Target Mol | T1826-1mg | 1mg | 现货 |
化合物 Voxtalisib Analogue PI3K-IN-1 |
98% |
|
|
Target Mol | T1826-2mg | 2mg | 现货 |
化合物 Voxtalisib Analogue PI3K-IN-1 |
98% |
|
|
Target Mol | T1826-5mg | 5mg | 现货 |
化合物 Voxtalisib Analogue PI3K-IN-1 |
98% |
|
|
Target Mol | T1826-10mg | 10mg | 现货 |
化合物 Voxtalisib Analogue PI3K-IN-1 |
98% |
|
|
Target Mol | T1826-25mg | 25mg | 现货 |
化合物 Voxtalisib Analogue PI3K-IN-1 |
98% |
|
|
Target Mol | T1826-50mg | 50mg | 现货 |
化合物 Voxtalisib Analogue PI3K-IN-1 |
98% |
|
|
Target Mol | T1826-100mg | 100mg | 现货 |
化合物 Voxtalisib Analogue PI3K-IN-1 |
98% |
|
|
Target Mol | T1826-500mg | 500mg | 现货 |
化合物 Voxtalisib Analogue PI3K-IN-1 |
98% |
|
|
Am | A781923-5mg | 5mg | 现货 |
PI3K-IN-1 PI3K-IN-1 |
98+% |
|
|
Am | A781923-10mg | 10mg | 现货 |
PI3K-IN-1 PI3K-IN-1 |
98+% |
|
|
Am | A781923-2mg | 2mg | 现货 |
PI3K-IN-1 PI3K-IN-1 |
98+% |
|
|
Am | A781923-25mg | 25mg | 现货 |
PI3K-IN-1 PI3K-IN-1 |
98+% |
|
|
Am | A781923-50mg | 50mg | 现货 |
PI3K-IN-1 PI3K-IN-1 |
98+% |
|
|
MCE | HY-12068-100mg | 100mg | 现货 |
PI3K-IN-1 PI3K-IN-1 |
99.93% |
|
|
MCE | HY-12068-50mg | 50mg | 现货 |
PI3K-IN-1 PI3K-IN-1 |
99.93% |
|
|
MCE | HY-12068-25mg | 25mg | 现货 |
PI3K-IN-1 PI3K-IN-1 |
99.93% |
|
|
MCE | HY-12068-10mg | 10mg | 现货 |
PI3K-IN-1 PI3K-IN-1 |
99.93% |
|
|
MCE | HY-12068-10mM*1mL | 10mM*1mL | 现货 |
PI3K-IN-1 PI3K-IN-1 |
99.93% |
|
|
MCE | HY-12068-5mg | 5mg | 现货 |
PI3K-IN-1 PI3K-IN-1 |
99.93% |
|
|
MCE | HY-12068-2mg | 2mg | 现货 |
PI3K-IN-1 PI3K-IN-1 |
99.93% |
|
|